Suppr超能文献

体外膜肺氧合治疗急性呼吸窘迫综合征时的难治性肺心病:转换为静脉-肺动脉辅助的作用——病例系列

Refractory cor pulmonale under extracorporeal membrane oxygenation for acute respiratory distress syndrome: the role of conversion to veno-pulmonary arterial assist-a case series.

作者信息

Bagate François, Masi Paul, Boukantar Madjid, Radu Costin, Saiydoun Gabriel, Fiore Antonio, Chiaroni Paul-Matthieu, Teiger Emmanuel, Folliguet Thierry, Gallet Romain, Mekontso Dessap Armand

机构信息

AP-HP, Hôpitaux Universitaires Henri Mondor, DHU A-TVB, Service de Médecine Intensive Réanimation, Créteil, France.

Université Paris Est Créteil, Faculté de Médecine, Groupe de recherche clinique CARMAS, Créteil, France.

出版信息

Front Med (Lausanne). 2024 Apr 25;11:1348077. doi: 10.3389/fmed.2024.1348077. eCollection 2024.

Abstract

INTRODUCTION

Pulmonary vascular dysfunction during severe acute respiratory distress syndrome (ARDS) may lead to right ventricle (RV) dysfunction and acute cor pulmonale (ACP). The occurrence/persistence of ACP despite conventional extracorporeal membrane oxygenation (ECMO) is a challenging situation. We explored the usefulness of a specific dual-lumen cannula that bypasses the RV, and on which a veno-pulmonary arterial assist (V-P ECMO) was mounted, in ARDS patients.

METHODS

We report a case-series of ARDS patients put on conventional veno-arterial or veno-venous ECMO and presented refractory ACP as an indication for a reconfiguration to V-P ECMO using the ProtekDuo cannula. The primary endpoint was the mitigation of RV and pulmonary vascular dysfunction as assessed by the change in end-diastolic RV/left ventricle (LV) surface ratio.

RESULTS

Six patients had their conventional ECMO reconfigured to V-P ECMO to treat refractory ACP. There was a decrease in end-diastolic RV/LV surface ratio, as well as end-systolic LV eccentricity index, and lactatemia immediately after V-P ECMO initiation. The resolution of refractory ACP was immediately achieved in four of our six (66%) patients. The V-P ECMO was weaned after a median of 26 [8-93] days after implantation. All but one patient were discharged home. We detected one case of severe hemolysis with V-P ECMO and two suspected cases of right-sided infective endocarditis.

CONCLUSION

V-P ECMO is useful to mitigate RV overload and to improve hemodynamics in case of refractory ACP despite conventional ECMO.

摘要

引言

重症急性呼吸窘迫综合征(ARDS)期间的肺血管功能障碍可能导致右心室(RV)功能障碍和急性肺心病(ACP)。尽管采用了传统的体外膜肺氧合(ECMO),但ACP的发生/持续存在仍是一个具有挑战性的情况。我们探讨了一种特定的双腔插管在ARDS患者中的实用性,该插管绕过右心室,并在其上安装了静脉-肺动脉辅助(V-P ECMO)。

方法

我们报告了一系列ARDS患者的病例,这些患者接受了传统的静脉-动脉或静脉-静脉ECMO治疗,并出现难治性ACP,这是使用ProtekDuo插管重新配置为V-P ECMO的指征。主要终点是通过舒张末期右心室/左心室(LV)表面积比的变化评估右心室和肺血管功能障碍的减轻情况。

结果

6例患者将其传统的ECMO重新配置为V-P ECMO以治疗难治性ACP。在启动V-P ECMO后,舒张末期右心室/左心室表面积比、收缩末期左心室偏心指数和乳酸血症立即下降。我们的6例患者中有4例(66%)立即实现了难治性ACP的缓解。V-P ECMO在植入后中位26 [8 - 93]天撤离。除1例患者外,所有患者均出院回家。我们检测到1例V-P ECMO导致的严重溶血病例和2例疑似右侧感染性心内膜炎病例。

结论

对于尽管采用了传统ECMO但仍为难治性ACP的情况,V-P ECMO有助于减轻右心室负荷并改善血流动力学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/11079173/04eb2de80c39/fmed-11-1348077-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验